Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-13-000723
Filing Date
2013-06-25
Accepted
2013-06-25 18:43:51
Documents
1
Period of Report
2013-06-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 8629
  Complete submission text file 0000904454-13-000723.txt   10051
Mailing Address ONE PALMER SQUARE PRINCETON NJ 08542
Business Address
SCHOEMAKER KATHLEEN K (Reporting) CIK: 0001207789 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 13933018

Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations